ホーム › 腎臓がん（腎細胞がん） › コロラド州
コロラド州における腎臓がん（腎細胞がん）の臨床試験
コロラド州内の拠点で、腎臓がん（腎細胞がん）に関する15件の研究が参加者を募集しています。
コロラド州内の都市
公式研究テキスト（英語）
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
- University of Colorado Anschutz Medical Campus, Aurora
- Rocky Mountain Cancer Centers, LLP, Lone Tree
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06234605Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
- Penrose-Saint Francis Healthcare, Colorado Springs
- 他15件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #87, Littleton
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
- UCHealth University of Colorado Hospital, Aurora
- UCHealth - Cherry Creek, Denver
- Poudre Valley Hospital, Fort Collins
- 他5件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT05327686Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Rocky Mountain Cancer Centers,LLP, Aurora
- Clinical and Translational Research Center(CTRC), Aurora
- University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP), Aurora
- 他8件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07227415ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of Colorado, Aurora
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
- UCHealth University of Colorado Hospital, Aurora
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
- 他7件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06661720Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Sarah Cannon Research Institute - Denver DDU, Denver
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/27更新 · NCT06582017Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial
- University of Colorado Anschutz Medical Campus, Aurora
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/21更新 · NCT06432036A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- Sarah Cannon Research Institute (SCRI), Denver
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/09更新 · NCT03972657KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Sarah Cannon Research Institute at HealthONE, Denver
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/08更新 · NCT06026410A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- University of Colorado Cancer Center, Aurora
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/13更新 · NCT06362369Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
- University of Colorado Cancer Center, Aurora
- Hilands Ranch Hospital, Highlands Ranch
- Lone Tree Medical Center, Lone Tree
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/13更新 · NCT05969496Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- Sarah Cannon Research Institute at HealthONE, Denver
被験者募集中第1/2相
18歳以上 · 全性別 · 2024/11/15更新 · NCT04787042ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。